NO873132D0 - MACROCYCLIC COMPOUNDS. - Google Patents
MACROCYCLIC COMPOUNDS.Info
- Publication number
- NO873132D0 NO873132D0 NO873132A NO873132A NO873132D0 NO 873132 D0 NO873132 D0 NO 873132D0 NO 873132 A NO873132 A NO 873132A NO 873132 A NO873132 A NO 873132A NO 873132 D0 NO873132 D0 NO 873132D0
- Authority
- NO
- Norway
- Prior art keywords
- carbon atoms
- groups
- group
- chain
- straight
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic Table
- C07F13/005—Compounds without a metal-carbon linkage
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/003—Compounds containing elements of Groups 3 or 13 of the Periodic Table without C-Metal linkages
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Radiology & Medical Imaging (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Hydrogenated Pyridines (AREA)
- Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
- Polyethers (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
Compounds of the general formula I <IMAGE> in which Y is a nitrogen or phosphorus atom, A<1> and A<2> are identical or different and are each a straight-chain or branched alkylene group having 2 to 6 carbon atoms, U<1>, U<2>, U<3>, U<4> are identical or different and are each a direct bond or a straight-chain or branched alkylene group having 1 to 6 carbon atoms, D<1>, D<2>, D<3>, D<4> are identical or different and are each an oxygen or sulphur atom, an alkylene group having 1 to 6 carbon atoms or a group N-R<7> where R<7> has the meaning of a hydrogen atom, a straight-chain or branched alkylene chain having 1 to 4 carbon atoms, which carries a COOR<1> group at the end, in which R<1> represents a hydrogen atom or a metal ion equivalent, D<5> has the meaning given for D<1>, D<2>, D<3> and D<4> and the group <IMAGE> where R<5> has the meaning of a hydrogen atom or of a straight-chain or branched, saturated or unsaturated C1-C20-alkylene group which may contain imino, phenyleneoxy, phenyleneimino, amide, ester groups, oxygen, sulphur and/or nitrogen atoms and may be substituted by hydroxyl, mercapto, imino and/or amino groups and has either a functional group or bound via this group a macromolecule B at the end, s and t are integers from 0 to 5, R<2> is hydrogen, a linear or branched, saturated or unsaturated, alkyl, acyl or acylalkyl group of 1 to 16 carbon atoms which is unsubstituted or substitute by one or more hydroxyl or lower alkoxy groups, or is -CH2-X-V where X has the meaning of carbonyl, of a straight-chain or branched alkylene group having 0 to 10 carbon atoms, which is unsubstituted or substituted by one or more hydroxyl or lower alkoxy groups, or of a straight &tilde& chain or branched alkylene group having 2 to 23 carbon atoms which is interrupted by oxygen atoms, V has the meaning <IMAGE> or -COOR<6> in which R<3> and R<4>, independently of one another, are hydrogen, a linear o branched alkyl group having 1 to 16 carbon atoms which is unsubstituted or substituted by one or more hydroxyl or lower alkoxy groups, or R<3> and R<4> together with the nitrogen atom represent a saturated 5- or 6-membered ring which may contain a further hetero atom and R<6> represents hydrogen or a saturated, unsaturated, straight-chain or branched or cyclic hydrocarbon radical having up to 16 carbon atoms or represents an aryl or aralkyl group, or R<2> or R<3> denotes a second macrocycle of the formula I' <IMAGE> which is bound via an alkylene chain (K) containing 2 to 20 carbon atoms, which, if desired carries carbonyl groups at the ends and, if desired, is interrupted by one or more oxygen atoms or R<1>-carboxymethylimino groups or substituted by one or more hydroxyl, lower alkoxy or carboxy-lower alkyl groups, which macrocycle can have a structure which is different from that of the parent structure, or R<2> denotes B or CH2-COB, with the proviso that if Rz represents B or CH2-COB, R<5> denotes a hydrogen atom, that at least two COORi groups are present in the molecule and that two hetero atoms of the macrocycle are each bound to at least two carbon atoms via an alkylene group and functional groups present in the molecule are, if desired conjugated with macromolecules and, if desired free carboxyl groups have been converted with organic or inorganic bases or amino acids and basic groups with inorganic or organic acids to the salts.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3625417A DE3625417C2 (en) | 1986-07-28 | 1986-07-28 | Tetraazacyclododecane derivatives |
Publications (4)
Publication Number | Publication Date |
---|---|
NO873132D0 true NO873132D0 (en) | 1987-07-27 |
NO873132L NO873132L (en) | 1988-01-29 |
NO174048B NO174048B (en) | 1993-11-29 |
NO174048C NO174048C (en) | 1994-03-09 |
Family
ID=6306101
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO873132A NO174048C (en) | 1986-07-28 | 1987-07-27 | Macrocyclic compounds and diagnostic agents containing them |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0255471B1 (en) |
JP (1) | JPH0753720B2 (en) |
AT (1) | ATE80391T1 (en) |
CA (1) | CA1341176C (en) |
DE (2) | DE3625417C2 (en) |
DK (1) | DK171574B1 (en) |
ES (1) | ES2052599T3 (en) |
GR (1) | GR3005808T3 (en) |
IE (1) | IE60677B1 (en) |
NO (1) | NO174048C (en) |
NZ (1) | NZ221225A (en) |
PT (1) | PT85410B (en) |
ZA (1) | ZA875561B (en) |
Families Citing this family (86)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5064633A (en) * | 1984-06-04 | 1991-11-12 | The Dow Chemical Company | Macrocyclic aminophosphonic acid complexes, their formulations and use |
US4885363A (en) * | 1987-04-24 | 1989-12-05 | E. R. Squibb & Sons, Inc. | 1-substituted-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs |
US5132409A (en) * | 1987-01-12 | 1992-07-21 | Bracco Industria Chimica S.P.A. | Macrocyclic chelating agents and chelates thereof |
IT1224416B (en) * | 1987-12-24 | 1990-10-04 | Bracco Ind Chimica Spa | MACROCYCLIC CHELANTS AND THEIR CHELATES |
FR2637895B1 (en) * | 1988-10-14 | 1992-11-06 | Guerbet Sa | NOVEL NITROGEN CYCLIC LIGANDS, METAL COMPLEXES FORMED BY THESE LIGANDS, DIAGNOSTIC COMPOSITIONS CONTAINING THESE COMPLEXES AND PROCESS FOR THE PREPARATION OF LIGANDS |
FR2614020B1 (en) * | 1987-04-14 | 1989-07-28 | Guerbet Sa | NOVEL NITROGEN CYCLIC LIGANDS, METAL COMPLEXES FORMED BY SUCH LIGANDS, DIAGNOSTIC COMPOSITIONS CONTAINING THESE COMPLEXES AND PROCESS FOR PREPARING LIGANDS. |
US5049667A (en) * | 1987-04-14 | 1991-09-17 | Guerbet S.A. | Nitrogen-containing cyclic ligands |
DE3713842A1 (en) * | 1987-04-22 | 1988-11-17 | Schering Ag | SUBSTITUTED CYCLIC COMPLEX MAKERS, COMPLEX AND COMPLEX SALTS, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL AGENTS CONTAINING THEM |
ES2086445T3 (en) * | 1987-07-16 | 1996-07-01 | Nycomed Imaging As | AMINO CARBOXYLIC ACIDS AND THEIR DERIVATIVES. |
US5531978A (en) * | 1987-07-16 | 1996-07-02 | Nycomed Imaging As | Aminopolycarboxylic acids and derivatives thereof |
GB8719042D0 (en) | 1987-08-12 | 1987-09-16 | Parker D | Conjugate compounds |
GB8719041D0 (en) * | 1987-08-12 | 1987-09-16 | Parker D | Conjugate compounds |
JPH0720989B2 (en) * | 1988-05-25 | 1995-03-08 | アメリカ合衆国 | Macrocyclic chelate conjugates and diagnostic test methods |
ATE120457T1 (en) * | 1988-06-24 | 1995-04-15 | Dow Chemical Co | MACROCYCLIC BIFUNCTIONAL CHELATING AGENTS, COMPLEXES THEREOF AND THEIR CONJUGATE ANTIBODIES. |
ZA894792B (en) * | 1988-06-24 | 1991-04-24 | Dow Chemical Co | Macrocyclic bifunctional chelants,complexes thereof and their antibody conjugates |
US5756065A (en) * | 1988-06-24 | 1998-05-26 | The Dow Chemical Company | Macrocyclic tetraazacyclododecane conjugates and their use as diagnostic and therapeutic agents |
DE4001655A1 (en) * | 1990-01-18 | 1991-07-25 | Schering Ag | 6-RING MACROCYCLIC TETRAAZA COMPOUNDS, METHOD FOR PRODUCING THE SAME AND PHARMACEUTICAL PRODUCTS CONTAINING THEM |
US4889931A (en) * | 1988-09-27 | 1989-12-26 | Salutar, Inc. | Manganese (II) chelate manufacture |
US5314681A (en) * | 1988-12-23 | 1994-05-24 | Nycomed Innovation Ab | Composition of positive and negative contrast agents for electron spin resonance enhanced magnetic resonance imaging |
US5342936A (en) * | 1989-02-10 | 1994-08-30 | David Parker | Tetra-aza macrocycles and processes for their preparation |
JPH03504510A (en) * | 1989-02-10 | 1991-10-03 | セルテック リミテッド | Azamacrocycle and its manufacturing method |
US5247077A (en) * | 1989-06-23 | 1993-09-21 | Celltech Limited | Tri-aza macrocycles and processes for their preparation |
GB9320277D0 (en) * | 1993-10-01 | 1993-11-17 | Nycomed Salutar Inc | Chelants |
GB8923843D0 (en) * | 1989-10-23 | 1989-12-13 | Salutar Inc | Compounds |
US5446145A (en) * | 1990-01-19 | 1995-08-29 | Nycomed Salutar, Inc. | Polychelant compounds |
US5650133A (en) * | 1990-01-19 | 1997-07-22 | Nycomed Salutar | Macrocyclic polyaza dichelates linked through ring nitrogens via an amide or ester functionality |
US5972307A (en) * | 1989-10-23 | 1999-10-26 | Nycomed Salutar, Inc. | Dichelants |
JP3250220B2 (en) * | 1989-10-23 | 2002-01-28 | ニコムド サルター インコーポレーテッド | Multi-site metal chelators |
AU625529B2 (en) * | 1989-12-22 | 1992-07-16 | E.R. Squibb & Sons, Inc. | 10-(2'-hydroxy-3'-alkoxy-1,4,7-triscarboxymethyl-1,4,7,10- tetraazacyclododecanes |
AU6709390A (en) * | 1989-12-22 | 1991-06-27 | E.R. Squibb & Sons, Inc. | 10-(2'-hydroxy-3'-polyoxaalkyl)-1,4,7-tris-carboxymethyl -1,4,7,10-tetraazacyclododecane |
CH679742A5 (en) * | 1990-01-09 | 1992-04-15 | Byk Gulden Lomberg Chem Fab | |
US5679810A (en) * | 1990-01-19 | 1997-10-21 | Salutar, Inc. | Linear oligomeric polychelant compounds |
DE4009119A1 (en) * | 1990-03-19 | 1991-09-26 | Schering Ag | 1,4,7,10-TETRAAZACYCLODODECANE-BUTYLTRIOLS, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL AGENTS CONTAINING THEM |
EP0522007A4 (en) * | 1990-03-26 | 1993-06-16 | Us Commerce | A fonctionalized complexand |
DK0455380T3 (en) * | 1990-04-18 | 1997-02-03 | Celltech Therapeutics Ltd | Tetraaza Macrocycles, Methods of Preparation and Their Use for Magnetic Resona ns Visualization |
US5684135A (en) * | 1990-04-18 | 1997-11-04 | Celltech Therapeutics Limited | Conjugate compounds containing aza-macro-cycles and processes for their preparation |
CA2039399C (en) * | 1990-04-25 | 2000-09-05 | C. Allen Chang | Dual functioning excipient for metal chelate contrast agents |
US5162109A (en) * | 1990-09-13 | 1992-11-10 | Mallinckrodt Medical, Inc. | Magnetic resonance imaging agents |
GB9024208D0 (en) * | 1990-11-07 | 1990-12-19 | Salutar Inc | Compounds |
DE4035760A1 (en) * | 1990-11-08 | 1992-05-14 | Schering Ag | MONO-N-SUBSTITUTED 1,4,7,10-TETRAAZACYCLODODECAN DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL AGENTS CONTAINING THEM |
EP0660925A1 (en) * | 1990-11-21 | 1995-07-05 | Mallinckrodt Medical, Inc. | Alkoxyamide derivatized chelates for mri |
DE4115789A1 (en) * | 1991-05-10 | 1992-11-12 | Schering Ag | MACROCYCLIC POLYMER COMPLEX IMAGERS, THEIR COMPLEXES, METHOD FOR THEIR PRODUCTION AND THE PHARMACEUTICAL AGENTS CONTAINING THEM |
DE4237943C2 (en) * | 1992-11-06 | 1997-10-23 | Schering Ag | Process for the preparation of metal complexes of N-beta-hydroxyalkyl-tri-N-carboxyalkyl-1,4,7,10-tetraazacyclododecane and N-beta-hydroxyalkyl-tri-N-carboxyalkyl-1,4,8,11-tetraazacyclotetradecane Derivatives |
DE4140779A1 (en) * | 1991-12-06 | 1993-06-09 | Schering Ag Berlin Und Bergkamen, 1000 Berlin, De | METHOD FOR PRODUCING MONO-N SUBSTITUTED TETRAAZAMACROCYCLES |
CA2092596A1 (en) * | 1992-03-27 | 1993-09-28 | Kan Kubomura | Tetraazacyclododecane derivative and its use |
US5310535A (en) * | 1992-04-24 | 1994-05-10 | The Dow Chemical Company | Carboxamide modified polyamine chelators and radioactive complexes thereof for conjugation to antibodies |
DE4218744C2 (en) * | 1992-06-04 | 1997-11-06 | Schering Ag | Process for the preparation of N-β-hydroxyalkyl-tri-N-carboxylalkyl-1,4,7,10-tetraazacyclododecane and N-β-hydroxyalkyl-tri-N-carboxyalkyl-1,4,8,11-tetraazacyclotetradecane derivatives and their metal complexes |
WO1994008630A1 (en) * | 1992-10-13 | 1994-04-28 | Mallinckrodt Medical, Inc. | Novel compositions for magnetic resonance imaging |
DE4317588C2 (en) * | 1993-05-24 | 1998-04-16 | Schering Ag | Macrocyclic metal complexes containing fluorine, process for their preparation and their use |
DE4318369C1 (en) * | 1993-05-28 | 1995-02-09 | Schering Ag | Use of macrocyclic metal complexes as temperature probes |
GB9318550D0 (en) * | 1993-09-07 | 1993-10-20 | Nycomed Salutar Inc | Chelants |
US5358704A (en) * | 1993-09-30 | 1994-10-25 | Bristol-Myers Squibb | Hepatobiliary tetraazamacrocyclic magnetic resonance contrast agents |
DE4340809C2 (en) * | 1993-11-24 | 2000-08-03 | Schering Ag | 1.4,7,10-tetraazacyclododecane derivatives, pharmaceutical compositions containing them and process for their preparation |
US6693190B1 (en) | 1994-05-11 | 2004-02-17 | Bracco International B.V. | Enhanced relaxivity monomeric and multimeric compounds |
CA2225453C (en) * | 1995-06-26 | 2004-12-14 | Concat, Ltd. | Compounds with chelation affinity and selectivity for first transition series elements, and their use in medical therapy and diagnosis |
DE19652386A1 (en) * | 1996-12-04 | 1998-06-10 | Schering Ag | Process for the preparation of metal complex carboxamides |
DE19744003B4 (en) * | 1997-09-26 | 2004-07-08 | Schering Ag | Contrast agent for infarct and necrosis imaging |
IT1297035B1 (en) * | 1997-12-30 | 1999-08-03 | Bracco Spa | 1,4,7,10-TETRAAZACICLODODECAN-1,4-DIACETIC ACID DERIVATIVES |
DE19849465A1 (en) * | 1998-10-21 | 2000-04-27 | Schering Ag | New dimeric ion pairs containing cationic and anionic metal complexes; useful as low viscosity contrast agents for X-ray, magnetic resonance and radiodiagnostic techniques, and as radiotherapy agents |
WO2000076556A2 (en) | 1999-06-11 | 2000-12-21 | Neorx Corporation | High dose radionuclide complexes for bone marrow suppression |
US7094885B2 (en) | 1999-07-11 | 2006-08-22 | Neorx Corporation | Skeletal-targeted radiation to treat bone-associated pathologies |
WO2001028982A1 (en) * | 1999-10-22 | 2001-04-26 | Mitsubishi Pharma Corporation | Diethylenetriaminepenta acetic acid derivatives |
FR2802928B1 (en) * | 1999-12-22 | 2003-01-31 | Air Liquide | POLYAZACYCLOALCANES POSSIBLY GRAFT ON A SOLID MATRIX, ORGANOMETALLIC COMPLEXES INCORPORATING THEM AS LIGANDS. USE OF SAID COMPOUNDS FOR THE EXTRACTION OF HEAVY METALS |
JP2004536034A (en) | 2001-01-08 | 2004-12-02 | ネオルクス コーポレイション | Therapeutic and diagnostic compounds, compositions and methods |
WO2006124726A2 (en) | 2005-05-12 | 2006-11-23 | The General Hospital Corporation | Novel biotinylated compositions |
DE102007002726A1 (en) | 2007-01-18 | 2008-07-31 | Bayer Schering Pharma Aktiengesellschaft | New cascade polymer complexes, processes for their preparation and pharmaceutical compositions containing them |
US10189803B2 (en) | 2008-02-22 | 2019-01-29 | Illinois Institute Of Technology | Synthesis of therapeutic and diagnostic drugs centered on regioselective and stereoselective ring opening of aziridinium ions |
WO2010011367A2 (en) * | 2008-02-22 | 2010-01-28 | Illinois Institute Of Technology | Bimodal ligands with macrocyclic and acyclic binding moieties, complexes and compositions thereof, and methods of using |
US9446995B2 (en) | 2012-05-21 | 2016-09-20 | Illinois Institute Of Technology | Synthesis of therapeutic and diagnostic drugs centered on regioselective and stereoselective ring opening of aziridinium ions |
US10556873B2 (en) | 2008-02-22 | 2020-02-11 | Illinois Institute Of Technology | Bimodal ligands with macrocyclic and acyclic binding moieties, complexes and compositions thereof, and methods of using |
DE102009053171B4 (en) | 2009-11-04 | 2011-07-21 | Bayer Schering Pharma Aktiengesellschaft, 13353 | Process for the preparation of the calcium complex of dihydroxy-hydroxy-methylpropyl-tetraazacyclododecane-triacetic acid (Calcobutrol) |
WO2011054480A1 (en) | 2009-11-09 | 2011-05-12 | Bayer Schering Pharma Aktiengesellschaft | Gadobutrol production by means of a ceramic membrane |
DE102009057274B4 (en) | 2009-12-02 | 2011-09-01 | Bayer Schering Pharma Aktiengesellschaft | Gadobutrol preparation using trioxobicyclo-octane |
DE102010013833A1 (en) | 2010-03-29 | 2011-09-29 | Bayer Schering Pharma Aktiengesellschaft | Producing gadolinium complex of N-(hydroxymethyl-dihydroxypropyl)-triscarboxymethyl-tetraazacyclododecane useful as magnetic resonance imaging contrast agent, comprises e.g. reacting cyclic compound with dimethylformamide dimethylacetal |
DK2896405T3 (en) | 2011-04-21 | 2020-04-06 | Bayer Ip Gmbh | Preparation of high purity gadobutrol |
EP2890788A1 (en) | 2012-08-31 | 2015-07-08 | The General Hospital Corporation | Biotin complexes for treatment and diagnosis of alzheimer's disease |
WO2015051362A1 (en) | 2013-10-04 | 2015-04-09 | Illinois Institute Of Technology | Multifunctional chelators, complexes, and compositions thereof, and methods of using same |
EP3101012A1 (en) | 2015-06-04 | 2016-12-07 | Bayer Pharma Aktiengesellschaft | New gadolinium chelate compounds for use in magnetic resonance imaging |
CA3002897C (en) * | 2015-12-10 | 2022-03-29 | Bracco Imaging Spa | Dimeric contrast agents |
DK3519394T3 (en) | 2016-09-27 | 2020-08-17 | Bayer Pharma AG | METHOD OF PREPARING THE CRYSTALLINIC FORM OF MODIFICATION A OF CALCOBUTROL |
CA3044877A1 (en) | 2016-11-28 | 2018-05-31 | Bayer Pharma Aktiengesellschaft | High relaxivity gadolinium chelate compounds for use in magnetic resonance imaging |
HUE056114T2 (en) * | 2016-12-12 | 2022-01-28 | Bracco Imaging Spa | Dimeric contrast agents |
CN108358954B (en) * | 2018-01-17 | 2019-10-29 | 南开大学 | A kind of chirality rare earth-NO free radical single-chain magnets and preparation method thereof |
EP3883613A1 (en) | 2018-11-23 | 2021-09-29 | Bayer Aktiengesellschaft | Formulation of contrast media and process of preparation thereof |
CN110357828B (en) * | 2019-08-13 | 2021-03-19 | 牡丹江医学院 | A kind of nuclear magnetic resonance contrast agent and its preparation method and use |
CN118955414B (en) * | 2024-10-17 | 2025-03-18 | 南昌大学 | Amphiphilic Eu complex and its preparation method and application in detecting tetracycline |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL194579C (en) * | 1983-01-21 | 2002-08-05 | Schering Ag | Diagnostic. |
DE3316703A1 (en) * | 1983-05-04 | 1984-11-08 | Schering AG, 1000 Berlin und 4709 Bergkamen | ORAL CONTRAST AGENT FOR MRI MRI AND THE PRODUCTION THEREOF |
US4639365A (en) * | 1984-10-18 | 1987-01-27 | The Board Of Regents, The University Of Texas System | Gadolinium chelates as NMR contrast agents |
DE3772785D1 (en) * | 1986-01-23 | 1991-10-17 | Squibb & Sons Inc | 1-SUBSTITUTED-4,7,10-TRISCARBOXYMETHYL-1,4,7,10-TETRAAZACYCLODODECAN AND ANALOG. |
GB8603537D0 (en) * | 1986-02-13 | 1986-03-19 | Parker D | Conjugate compound |
-
1986
- 1986-07-28 DE DE3625417A patent/DE3625417C2/en not_active Expired - Lifetime
-
1987
- 1987-07-24 ES ES87730085T patent/ES2052599T3/en not_active Expired - Lifetime
- 1987-07-24 DE DE8787730085T patent/DE3781620D1/en not_active Expired - Lifetime
- 1987-07-24 AT AT87730085T patent/ATE80391T1/en not_active IP Right Cessation
- 1987-07-24 EP EP87730085A patent/EP0255471B1/en not_active Expired - Lifetime
- 1987-07-27 PT PT85410A patent/PT85410B/en unknown
- 1987-07-27 CA CA000543027A patent/CA1341176C/en not_active Expired - Lifetime
- 1987-07-27 NO NO873132A patent/NO174048C/en not_active IP Right Cessation
- 1987-07-28 DK DK393387A patent/DK171574B1/en not_active IP Right Cessation
- 1987-07-28 ZA ZA875561A patent/ZA875561B/en unknown
- 1987-07-28 IE IE203887A patent/IE60677B1/en not_active IP Right Cessation
- 1987-07-28 NZ NZ221225A patent/NZ221225A/en unknown
- 1987-07-28 JP JP62186794A patent/JPH0753720B2/en not_active Expired - Lifetime
-
1992
- 1992-09-24 GR GR920402134T patent/GR3005808T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
IE60677B1 (en) | 1994-08-10 |
NO873132L (en) | 1988-01-29 |
AU7621787A (en) | 1988-02-04 |
CA1341176C (en) | 2001-01-30 |
EP0255471B1 (en) | 1992-09-09 |
NZ221225A (en) | 1990-09-26 |
PT85410B (en) | 1990-06-29 |
DE3781620D1 (en) | 1992-10-15 |
DE3625417C2 (en) | 1998-10-08 |
ZA875561B (en) | 1989-03-29 |
ATE80391T1 (en) | 1992-09-15 |
PT85410A (en) | 1987-08-01 |
GR3005808T3 (en) | 1993-06-07 |
NO174048C (en) | 1994-03-09 |
JPS6341468A (en) | 1988-02-22 |
DK393387A (en) | 1988-01-29 |
AU604249B2 (en) | 1990-12-13 |
DK171574B1 (en) | 1997-01-20 |
ES2052599T3 (en) | 1994-07-16 |
EP0255471A1 (en) | 1988-02-03 |
IE872038L (en) | 1988-01-28 |
JPH0753720B2 (en) | 1995-06-07 |
NO174048B (en) | 1993-11-29 |
DE3625417A1 (en) | 1988-02-11 |
DK393387D0 (en) | 1987-07-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK393387D0 (en) | MACROCYCLIC COMPOUNDS | |
KR910007704A (en) | Fibrinogen receptor antagonist | |
GR3005807T3 (en) | ||
ATE150659T1 (en) | USE OF ORGANOFUNCTIONALLY MODIFIED POLYSILOXANES FOR DEFOAMING DIESEL FUEL | |
MX165512B (en) | CARBAMATE ADDITIVE FOR LUBRICATING COMPOSITION | |
ATE53860T1 (en) | FUEL MIXTURE. | |
ES2035261T3 (en) | COMPOSITIONS OF OIL AND FUEL OIL CRUDES. | |
EP0250358A3 (en) | Novel complex compounds | |
EP0341925A3 (en) | An inorganic filler containing polyolefin composition | |
DE69203551D1 (en) | Biodegradable copolyester of 4-hydroxyproline and pharmaceutical composition containing it. | |
DE3772685D1 (en) | USE OF RARE EARTH MIXTURES TO STABILIZE FUELS FOR DIESEL ENGINES. | |
ATE189215T1 (en) | COMPOSITIONS, CONCENTRATES, LUBRICANT COMPOSITIONS, FUEL COMPOSITIONS, AND FUEL ECONOMY IMPROVEMENT METHOD OF INTERNAL COMBUSTION ENGINES | |
ATE38675T1 (en) | PHOSPHATE ESTER DERIVATIVES AND THEIR USE AS AN ANTI-CANCER AGENT. | |
FR2616663B1 (en) | NOVEL NITROGEN POLYCYCLIC STRUCTURE TRIPEPTIDES, PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | |
GB1489849A (en) | 4,4'-bi-piperidylidene derivatives and their use as polymer stabilizers | |
DE69006552D1 (en) | Formal compounds, fuel additives and fuel mixtures. | |
KR860002443A (en) | Method for preparing anthracene derivative | |
KR840001154A (en) | Method for preparing 1,2-dithiol-3-ylidene ammonium derivative | |
KR860007222A (en) | Method for preparing benzo [a] phenazine derivative | |
ES2012763B3 (en) | WELDING COMPOSITIONS. | |
KR890010089A (en) | Curable Resin Composition | |
DE3572815D1 (en) | 1,3-DITHIOLE DERIVATIVES |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK1K | Patent expired |